• Between a third and a half of approved small molecule therapeutics are derived from natural sources, but only a small proportion of the natural compounds have been identified and screened.
  • That is, until now. India-based business, Enveda Biosciences, is mapping nature's chemistry and enabling the healthcare industry to rapidly discover, develop and deliver new drugs. The company is delivering hope to millions of people suffering from complex diseases.
  • The company's platform is fast becoming a global search engine for new medicines. The platform uses advanced technologies to capture and catalog chemicals, creating a diverse and searchable dataset of small molecules for scientists seeking new treatments.
  • Before founding Enveda Biosciences, Viswa Colluru led multiple drug developments at Recursion Pharmaceuticals. He earned his PhD in immuno-oncology at the University of Wisconsin-Madison, where he developed therapies for prostate cancer.
Portrait of Viswa Colluru
My vision is to decode the chemistry of life to make people and the planet healthier. We want to have a profound and lasting impact on the health and well-being of children and adults worldwide. We will deliver hope to every patient.

Enveda Biosciences works towards this UN Sustainable Development Goal:

Other Global Visionaries you might find interesting:

Or you can view and select from all of our Global Visionaries